Draft Guidance for Clinical Investigators, Industry, and FDA Staff: Financial Disclosure by Clinical Investigators; Correction
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of May 24, 2011 (76 FR 30175). The document announced the availability of a draft guidance entitled “ Draft Guidance for Clinical Investigators, Industry, and FDA Staff: Financial Disclosure by Clinical Investigators.”The document was published with an incorrect docket number. This document corrects that error.
For further information contact:
Joyce Strong, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148.
In FR Doc. 2011-12623, appearing on page 30175, in the Federal Register of Tuesday, May 24, 2011, the following correction is made:
1. On page 30175, in the second column, in the Docket No. heading, “[Docket No. FDA-1999-D-0792] (Formerly FDA-1999-D-0792)” is corrected to read “[Docket No. FDA-1999-D-0742] (formerly Docket No. 1999D-4396)”.Dated: May 31, 2011. Leslie Kux, Acting Assistant Commissioner for Policy.